Secnidazole
Nitroimidazole Antimicrobial — ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: flagentyl, secnidazol, seknidazol, solosec
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Secnidazole is an ofp drug in the Nitroimidazole Antimicrobial class catalogued in DrugCentral. It was first approved by the FDA in 2017. DrugCentral lists 1 molecular target, including fabH. Recorded indications include Bacterial vaginosis, Giardiasis and Infection by Trichomonas.
- Approval status: ofp (first approved 2017 by the FDA).
- Drug class: Nitroimidazole Antimicrobial.
- Molecular targets: fabH (1 listed in DrugCentral).
- Indications: Bacterial vaginosis, Giardiasis and Infection by Trichomonas.
- ATC code: J01RA07 (Combinations of antibacterials).
- Molecular formula: C7H11N3O3; molecular weight 185.18 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (3)
- Bacterial vaginosis
- Giardiasis
- Infection by Trichomonas
Mechanism & targets
| Established pharmacologic class | Nitroimidazole Antimicrobial |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | fabH | unknown | IC50 4.55 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2017-09-15 | FDA | — | SYMBIOMIX THERAPEUTICS LLC |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01RA07 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › COMBINATIONS OF ANTIBACTERIALS › Combinations of antibacterials |
P01AB07 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES › Nitroimidazole derivatives |
Chemical structure
| Molecular formula | C7H11N3O3 |
|---|---|
| Molecular weight | 185.18 g/mol |
| CAS number | 3366-95-8 |
| InChIKey | KPQZUUQMTUIKBP-UHFFFAOYSA-N |
| PubChem CID | 71815 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Secnidazole used for?
DrugCentral lists the following indications for Secnidazole: Bacterial vaginosis, Giardiasis and Infection by Trichomonas.
How does Secnidazole work?
Its molecular targets in DrugCentral include fabH.
When was Secnidazole first approved?
Secnidazole was first approved by the FDA in 2017.
What drug class does Secnidazole belong to?
Secnidazole is in the Nitroimidazole Antimicrobial class.
What is the chemical formula of Secnidazole?
Secnidazole has the molecular formula C7H11N3O3 and a molecular weight of 185.18 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2427 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL498847 — compound record and bioactivity
- PubChem CID 71815 — chemical identifiers
- DrugBank DB12834 — drug record
- FDA UNII R3459K699K — substance identity
- DailyMed: FDA labels for Secnidazole — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.